retatrutide bad side effects UK Guide: Key Facts on the New Weight-Loss Drug Retatrutide: A Promising Option for

Rising prevalence of type 2 diabetes Increasing obese population in developed nations Increasing R&D investments to enhance clinical efficacy Adverse side effects associated with use of liraglutide and semaglutide Liraglutide and semaglutide are pharmaceutical medications categorized as glucagon-like peptide-1 receptor agonists (GLP-1 RAs)

Semaglutide (Ozempic, Wegovy) administered once weekly demonstrates injection site reaction rates of 1.2-1.4% according to FDA prescribing information

doi: 10.1016/j.ahj.2022.11.003 203 KayaACeylanAFKavutcuMSantamariaAoltsov PrnovMStefekMet al

Causal Inference : What If (CRC Press, 2010)